General Assembly Proposed Bill No. 545
January Session, 2017 LCO No. 2990
*02990*
Referred to Committee on INSURANCE AND REAL ESTATE
Introduced by:
SEN. KENNEDY, 12th Dist.
General Assembly
Proposed Bill No. 545
January Session, 2017
LCO No. 2990
*02990*
Referred to Committee on INSURANCE AND REAL ESTATE
Introduced by:
SEN. KENNEDY, 12th Dist.
AN ACT CONCERNING A STUDY OF REQUESTS BY HEALTH CARE PROVIDERS TO OVERRIDE STEP THERAPY DRUG REGIMENS FOR CERTAIN CANCER PATIENTS.
Be it enacted by the Senate and House of Representatives in General Assembly convened:
That the Insurance Commissioner shall study and report on (1) the processes that insurance companies, hospital service corporations, medical service corporations, health care centers and other entities that use step therapy for prescription drugs employ in assessing requests made by treating health care providers to override the use of step therapy drug regimens for insureds diagnosed with metastatic cancer, and (2) the response time to such requests.
Statement of Purpose:
To require a study and report on the processes that insurance companies, hospital service corporations, medical service corporations, health care centers and other entities that use step therapy for prescription drugs employ in assessing requests made by treating health care providers to override the use of step therapy drug regimens for insureds diagnosed with metastatic cancer and the response time to such requests.